DarioHealth Corp. (DRIO): Nasdaq/NYSE listing notice — DarioHealth receives Nasdaq extension to Sept 15, 2025 to regain $1 bid price

DarioHealth Corp.

Staff granted additional 180 days until September 15, 2025 to meet Minimum Bid Price Requirement.
Must close at or above $1.00 for 10 consecutive trading days to regain compliance.
Company considering measures including a potential stock split to address the deficiency.
No assurance compliance will be achieved; failure risks delisting from Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

DarioHealth Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 18, 2025, the Company received a letter (the “Letter”), from the Staff approving an extension of an additional 180 calendar days from the date of the Letter, or until September 15, 2025 (the “Additional Compliance Period”) to regain compliance with the Minimum Bid Price Requirement. The Company’s Common Stock will continue to trade under the symbol “DRIO.” If at any time during the Additional Compliance Period, the bid price of the Common Stock closes at or above $1.00 per share for a minimum of ten (10) consecutive trading days, Nasdaq will provide the Company with written confirmation

View on SEC.gov

Browse all listing & compliance notices →

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-025549

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.